← FDA Drug Approvals (Drugs@FDA)
FOSAPREPITANT DIMEGLUMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS · Approved 2017-03-28
Drug application
- FDA Application #
ANDA204845- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FOSAPREPITANT DIMEGLUMINE
- Generic name
- Fosaprepitant Dimeglumine
- Active ingredients
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- UNKNOWN
- Route
- UNKNOWN
- Marketing status
- None (Tentative Approval)
- Sponsor
- SAGENT PHARMS
- First approval
- 2017-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown